IGF-1 LR3, a modified version of insulin-like growth factor-1, has a longer half-life than standard IGF-1 because it does not bind to IGF-1 binding proteins well. It promotes cell division and growth, fat metabolism, muscle repair, and hypertrophy by inhibiting myostatin.
IGF-1 derivatives, including IGF1-LR3, stimulate cell division and proliferation in various tissues, but they do not promote cell enlargement. IGF1-LR3 also reduces blood sugar and insulin levels, making it a potential treatment for diabetes. It counteracts myostatin and promotes tissue repair and maintenance, making it a potential protective molecule against aging and various conditions.
Ongoing research is exploring its potential benefits in preventing dementia, muscle atrophy, and kidney disease.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION.
ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.